Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Tuberculosis

Free Subscription 04.02.2019 1 Am J Epidemiol 1 Am J Respir Crit Care Med 3 Clin Infect Dis 1 Eur J Clin Microbiol Infect Dis 2 Int J Tuberc Lung Dis 2 Lancet Glob Health 1 Lancet HIV 1 N Engl J Med 5 PLoS One 1 Respir Med 2 Trop Med Int Health

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Epidemiol

1. 
   RE: "PROSPECTS FOR TUBERCULOSIS ELIMINATION IN THE UNITED STATES: RESULTS OF A TRANSMISSION DYNAMIC MODEL".
   Am J Epidemiol. 2019;188:258.
   PubMed     Text format    
   
   

   
   Am J Respir Crit Care Med

2. DHEDA K, Lenders L, Srivastava S, Magombedze G, et al
   Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing.
   Am J Respir Crit Care Med. 2019 Jan 29. doi: 10.1164/rccm.201807-1361.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

3. WALSH KF, Vilbrun SC, Souroutzidis A, Delva S, et al
   Improved Outcomes with High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment in Haiti.
   Clin Infect Dis. 2019 Jan 29. pii: 5304006. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
4. BORAND L, de Lauzanne A, Nguyen NL, Cheng S, et al
   Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis.
   Clin Infect Dis. 2019 Jan 28. pii: 5303788. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
5. CHENG MP, Kusztos AE, Bold TD, Ho VT, et al
   Risk of Latent Tuberculosis Reactivation after Hematopoietic-Cell Transplantation.
   Clin Infect Dis. 2019 Jan 28. pii: 5303791. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Clin Microbiol Infect Dis

6. HODILLE E, Maisson A, Charlet L, Bauduin C, et al
   Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
   Eur J Clin Microbiol Infect Dis. 2019 Jan 24. pii: 10.1007/s10096-018-03463.
   PubMed     Text format     Abstract available
   
   

   
   Int J Tuberc Lung Dis

7. HANIFA Y, Toro Silva S, Karstaedt A, Sahid F, et al
   What causes symptoms suggestive of tuberculosis in HIV-positive people with negative initial investigations?
   Int J Tuberc Lung Dis. 2019 Jan 24. doi: 10.5588/ijtld.18.0251.
   PubMed     Text format     Abstract available
   
   
8. PALEIRON N, Soler C, Hassan MO, Andriamanantena D, et al
   First description of Mycobacterium tuberculosis and M. canettii concomitant infection: report of two cases.
   Int J Tuberc Lung Dis. 2019 Jan 24. doi: 10.5588/ijtld.18.0261.
   PubMed     Text format     Abstract available
   
   

   
   Lancet Glob Health

9. REDDY KP, Gupta-Wright A, Fielding KL, Costantini S, et al
   Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study.
   Lancet Glob Health. 2019;7:e200-e208.
   PubMed     Text format     Abstract available
   
   
10. ZWERLING A
    Costs of tuberculosis screening among inpatients with HIV.
    Lancet Glob Health. 2019;7:e163-e164.
    PubMed     Text format    
    
    

    
    Lancet HIV

11. DORWARD J, Lessells R, Drain PK, Naidoo K, et al
    Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research.
    Lancet HIV. 2018 Jun 5. pii: S2352-3018(18)30093.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

12. CHEN ST, Cahalane AM, Ryan ET, Foreman RK, et al
    Case 2-2019: A 36-Year-Old Man with Rash, Abdominal Pain, and Lymphadenopathy.
    N Engl J Med. 2019;380:275-283.
    PubMed     Text format    
    
    

    
    PLoS One

13. ALOTAIBI B, Yassin Y, Mushi A, Maashi F, et al
    Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 Hajj.
    PLoS One. 2019;14:e0210913.
    PubMed     Text format     Abstract available
    
    
14. 
    Correction: Kenya tuberculosis prevalence survey 2016: Challenges and opportunities of ending TB in Kenya.
    PLoS One. 2019;14:e0211593.
    PubMed     Text format     Abstract available
    
    
15. GUERRA J, Mogollon D, Gonzalez D, Sanchez R, et al
    Active and latent tuberculosis among inmates in La Esperanza prison in Guaduas, Colombia.
    PLoS One. 2019;14:e0209895.
    PubMed     Text format     Abstract available
    
    
16. BOGDANOVA EN, Mariandyshev AO, Balantcev GA, Eliseev PI, et al
    Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation.
    PLoS One. 2019;14:e0211203.
    PubMed     Text format     Abstract available
    
    
17. HIPPNER P, Sumner T, Houben RM, Cardenas V, et al
    Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa.
    PLoS One. 2019;14:e0209320.
    PubMed     Text format     Abstract available
    
    

    
    Respir Med

18. AZNAR ML, Zubrinic M, Siemienowicz M, Hashimoto K, et al
    Adjuvant lung resection in the management of nontuberculous mycobacterial lung infection: A retrospective matched cohort study.
    Respir Med. 2018;142:1-6.
    PubMed     Text format     Abstract available
    
    

    
    Trop Med Int Health

19. HERMANS S, Cornell M, Middelkoop K, Wood R, et al
    The differential impact of hiv and art on gender-specific tuberculosis rates.
    Trop Med Int Health. 2019 Jan 25. doi: 10.1111/tmi.13209.
    PubMed     Text format     Abstract available
    
    
20. PORMOHAMMAD A, Nasiri MJ, Riahi SM, Fallah F, et al
    Human immunodeficiency virus in patients with tuberculous meningitis: systematic review and meta-analysis.
    Trop Med Int Health. 2018;23:589-595.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: